Wegman-Ostrosky Talia, Savage Sharon A
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Research Division, Instituto Nacional de Cancerologia, Mexico City, Mexico.
Br J Haematol. 2017 May;177(4):526-542. doi: 10.1111/bjh.14535. Epub 2017 Feb 17.
The inherited bone marrow failure syndromes (IBMFS) typically present with significant cytopenias in at least one haematopoietic cell lineage that may progress to pancytopenia, and are associated with increased risk of cancer. Although the clinical features of the IBMFS are often diagnostic, variable disease penetrance and expressivity may result in diagnostic dilemmas. The discovery of the genetic aetiology of the IBMFS has been greatly facilitated by next-generation sequencing methods. This has advanced understanding of the underlying biology of the IBMFS and been essential in improving clinical management and genetic counselling for affected patients. Herein we review the clinical features, underlying biology, and new genomic discoveries in the IBMFS, including Fanconi anaemia, dyskeratosis congenita, Diamond Blackfan anaemia, Shwachman Diamond syndrome and some disorders of the myeloid and megakaryocytic lineages.
遗传性骨髓衰竭综合征(IBMFS)通常至少在一种造血细胞谱系中表现出严重的血细胞减少,可能进展为全血细胞减少,并与癌症风险增加相关。尽管IBMFS的临床特征通常具有诊断价值,但可变的疾病外显率和表达性可能导致诊断困境。下一代测序方法极大地促进了IBMFS遗传病因的发现。这增进了对IBMFS潜在生物学机制的理解,对于改善受影响患者的临床管理和遗传咨询至关重要。在此,我们综述了IBMFS的临床特征、潜在生物学机制和新的基因组发现,包括范可尼贫血、先天性角化不良、先天性纯红细胞再生障碍性贫血、施-戴综合征以及一些髓系和巨核细胞谱系疾病。